Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy.

Authors :: Pinnetti C
Baroncelli S
Villani P
Fantoni M
Tozzi V
De Luca A
Cauda R
Anzidei G
Cusato M
Regazzi M
Floridia M
Tamburrini E
Source :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2010 Sep; Vol. 65 (9), pp. 2050-2. Date of Electronic Publication: 2010 Jul 14.
Publication Year :: 2010

Subjects :: Adenine administration & dosage
Female
HIV Infections virology
Humans
Pregnancy
Pregnancy Complications, Infectious virology
Raltegravir Potassium
Tenofovir
Viral Load
Viremia
Adenine analogs & derivatives
Anti-HIV Agents administration & dosage
Antiretroviral Therapy, Highly Active methods
HIV Infections drug therapy
Organophosphonates administration & dosage
Pregnancy Complications, Infectious drug therapy
Pyrrolidinones administration & dosage
RNA, Viral blood

Full Text Access

Tools